Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Konecranes Plc - Managers' transactions - Juha Pankakoski

Konecranes Plc - Managers' transactions - Juha Pankakoski ____________________________________________   Person subject to the notification requirement Name: Pankakoski, Juha Position: Other senior manager Issuer: Konecranes Plc LEI: 549300EF0CDEQZBMA096   Notification type: INITIAL NOTIFICATION Reference number: 549300EF0CDEQZBMA096_20230810140217_365 ____________________________________________   Transaction date: 2023-08-09 Venue: XHEL Instrument type: SHARE ISIN: FI0009005870 Nature of the transaction: ACQUISITION   Transaction

Konecranes Plc - Managers' transactions - Teo Ottola

Konecranes Plc - Managers' transactions - Teo Ottola ____________________________________________   Person subject to the notification requirement Name: Ottola, Teo Position: Chief Financial Officer Issuer: Konecranes Plc LEI: 549300EF0CDEQZBMA096   Notification type: INITIAL NOTIFICATION Reference number: 549300EF0CDEQZBMA096_20230810140218_366 ____________________________________________   Transaction date: 2023-08-09 Venue: XHEL Instrument type: SHARE ISIN: FI0009005870 Nature of the transaction: ACQUISITION   Transaction details

Konecranes Plc - Managers' transactions - Sirpa Poitsalo

Konecranes Plc - Managers' transactions - Sirpa Poitsalo____________________________________________ Person subject to the notification requirementName: Poitsalo, SirpaPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20230810140217_364____________________________________________ Transaction date: 2023-08-09Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 47 Unit price: 31.9653

Pricer publishes prospectus in connection with the fully guaranteed rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD REQUIRE ADDITIONAL PROSPECTUS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE IS UNLAWFUL OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH ACTION. REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS

Report on managers' transactions in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 114 - 11 AUGUST 2023   Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.   Name:   Vibeke Bak SolokReason:   Reporting duty, Board MemberIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   PurchaseTrading date:

#23-73 Consolidation of shares in Arbona AB

At the general meeting of Arbona AB (“the Company”) on August 2, 2023, it was decided to merge the Company’s share classes whereby one (1) existing share of class B is merged into one (1) new share of class A (1:1). The last day of trading for the class B shares before the consolidation is August 15, 2023. The record date for the consolidation shall be August 17, 2023.   Information about the affected instrument:   Listing name: Arbona A Exchange symbol: ARBO A CFI-code: ESVUFR FISN-code: ARBONA/SH A ISIN-code: SE0003210590 Instrument-ID: 2M7N Number of

Eevia Health Plc to award Select Ingredients an exclusive sales contract on special grade of new cognitive health product.

Eevia Health Plc’s (”Eevia” or ”The Company”) is awarding an exclusive sales agreement to Select Ingredients for a new special formulation for a Tart Cherry extract which will be marketed under the tradename CherryMax®.  The sales agreement has binding volumes and minimum sales volume per year. This cooperation is expected to provide for a sales value of over USD 1 million in 2024 and with growth in the coming years.The CherryMax® is a special variant of the tart cherry product range Eevia manufactures. It has scientifically proved effects on human memory and concentration, as well as sleep

Checkin.com Group: Webcast of Quarterly Report Q2 2023 Thursday August 17th 08.30 CEST

Thursday August 17th 07.30 CEST Checkin.com Group publishes the quarterly report for Q2 2023 on the company’s website. In a webcast the same day at 08.30 CEST the report will be presented by the company’s CEO Kristoffer Cassel and CFO Martin Bäuml. The webcast (Swedish) will be available through this link:https://www.finwire.tv/webcast/checkin-com/q2-2023/The full report will be published on:https://group.checkin.com/investors/reports/ An english version of the webcast will be published on the company’s website later the same day.  For further information, please contact:

Healing the Baltic Sea is a shared responsibility – Consumer purchases can make a difference

This year, Kiilto will donate 0.02€ for every Kiilto, Erisan, Serto or Linna consumer product sold between 01 August 2023 and 30 September 2023, with a minimum promise of 24,000€ to the John Nurminen Foundation .Our shared Baltic Sea is sick Global climate change and local environmental pressures plague the Baltic Sea, affecting marine biodiversity and the lives of 90 million people in the catchment area. Despite being the youngest sea on Earth, the Baltic Sea is one of the most polluted bodies of water in Europe. Current human activities related to

Post-Stabilisation Announcement

11 August 2023 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. EU / ISIN EU000A3K4DT4  Stabilisation Notice Further to the pre-stabilisation period announcement dated July,11[th] 2023, Landesbank Baden-Württemberg (contact: Torsten Zittlau; telephone: +49 711 127 74640) hereby gives notice that no stabilisation (within the meaning of Art. 3.2 (d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilising Manager(s)

YIT to build a residential building for Asuntosäätiö in Jätkäsaari, Helsinki

YIT Corporation Press Release 11 August 2023 at 1:00 p.m.YIT has signed a contract with Asuntosäätiö to build residential building in Jätkäsaari, Helsinki. The value of the project to YIT is approximately EUR 16 million and it will be recorded in the order book for the third quarter of the year. The state-subsidised (ARA) residential building will have an area of approximately 7200 gross square metres and will comprise 82 housing rights apartments and one street-level commercial space. The higher part of the building will have eight storeys and the lower part six. The roof will be fitted

Axactor ASA: Invitation to presentation of Q2 2023 results

Axactor ASA will publish its second quarter 2023 results on Thursday 17 August 2023. 07:00 am CET: The report and presentation will be made available on axactor.com and newsweb.oslobors.no. 10:00 am CET: The results will be presented in a global investor webcast with a live Q&A session. A recording of the webcast will be made  available after the live stream is concluded on axactor.com. Webcast participation will be possible via the following: Streaming- https://eu-app.webinar.net/LD68XZ7YdVz Phone- Dial-in pin: 520967- Norway: +47 81 50 33 08- Sweden: +46 10 884 80

Veg of Lund signs distribution agreement with Synergy Trading Corporation for the Japanese market

Veg of Lund has entered into a distribution agreement to commence sales in the Japanese market. First trial order has been shipped from Europe and on shelves sales will commence with confirmed retail partners by the end of Q3.“Japan is not only a sizeable market but also a market to which other Asian countries look for direction from. Look forward to working with Synergy Trading on making DUG Potato drink a commercial success and continue other Asian discussions with a stamp of approval from the Japanese market,” says Fredrik Carling, CEO of Veg of Lund.   Synergy Trading Corporation

Notification of Executive’s transaction with Vestas shares

Vestas Wind Systems A/S, Aarhus, 11 August 2023Company Announcement no. 14/2023   In accordance with Article 19 (3) of the EU Market Abuse Regulation, Vestas Wind Systems A/S is required to disclose information regarding trading in Vestas Wind Systems A/S shares and securities by Executives and persons closely associated with an Executive.  The statement is based on reports which Vestas Wind Systems A/S has received from one of the Executives, see appendix.  Contact detailsVestas Wind Systems A/S, Denmark Daniel Patterson, Vice President Investor RelationsTel: +45

Friends support the community with free play group

A pair of friends from Staffordshire University have been praised after setting up a free community play group during their studies.Skye Gilbert and Courtney Lee from Stafford met while studying BA (Hons) Education Studies  and became close friends after they both became pregnant in their second year. They started the free play group ‘Fridays at Faraday’ as part of their studies and to address concerns about parents and children being isolated in their communities. Aimed at children between 0 – 5, the group at Faraday Road Children'

Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint

Press Release – Oslo, Norway, August 11, 2023: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that the Hexvix[®] Phase III bridging trial in China has successfully met its primary research endpoint.The objective of this multicenter Phase III trial is to support regulatory approval of Hexvix in Mainland China. The bridging trial is intended to confirm results from prior clinical trials regarding the safety and detection benefits of blue light cystoscopy (BLC®) with Hexvix compared to white light

NoHo Partners Plc: Managers' transactions (Niemi)

NoHo Partners PlcMANAGERS' TRANSACTIONS 11.8.2023 12:00NoHo Partners Plc: Managers' transactions (Niemi) ____________________________________________ Person subject to the notification requirementName: Hanna-Stiina NiemiPosition: Closely associated person (1):Person Discharging Managerial Responsibilities In IssuerName: Mika NiemiPosition: Member of the Board Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 36477/4/8____________________________________________ Transaction date: 2023-08-09Venue:

Major shareholder announcement

Company announcement 20/2023 With reference to section 30 of the Capital Markets Act, HusCompagniet A/S (the “Company”) hereby announces that Lind Value II ApS, owned by Henrik Lind through Lind Invest ApS, has notified the Company that Lind Value II ApS, holds 3,337,792 shares and 16,688,960 voting rights, corresponding to 15.37% of the total voting rights and the total share capital in the Company. For additional information, please contact: HusCompagniet Jesper Høybye, Group CFO                           +45 30 58 46 42About HusCompagniet HusCompagniet is a leading

Promising signals of effect in Annexin's RVO-study

Annexin Pharmaceuticals AB today announces that an independent evaluation of potential signals of effect has been carried out in the company's Phase 2-study in retinal vein occlusion with the investigational new drug ANXV. Positive findings justify an extended follow-up period.A group of leading independent US ophthalmologists has conducted an evaluation of the available information from patients treated so far in the placebo-controlled study. The evaluation confirmed an unexpectedly long duration of effect with a single dose of standard of care anti-VEGF treatment in two of five treated

Techstep ASA: Invitation to presentation of Q2 2023 financial results

Techstep ASA will release its second quarter 2023 financial results on Friday 18 August 2023 at 07:00 CET. The quarterly report and presentation will be made available on the company's website: www.techstep.io/investor, as well as on www.newsweb.no.   The Q2 presentation will be given in English by CEO, Børge Astrup and CFO, Ellen Solum.  A Q&A session will take place as a virtual event on 18 August at 08:00 CET. Please join the Teams-session by clicking here 

Contract awards in Brazil

Solstad Offshore ASA (Solstad) has been awarded two contracts from Brazilian Clients that further strengthen Solstad’s position as one of the main operators of high-end offshore vessels in Brazil. CSV Normand Pioneer has been awarded an extension of its charter contract with the Brazilian oil company PRIO for a period of 18 months to August 2025. The vessel will support PRIO’s E&P activities in Brazilian waters. Solstad and Equinor Brazil have entered into an agreement to convert the PSV Normand Carioca to a Well Stimulation Vessel (WSV) and extend the present contract until December

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 113 - 11 AUGUST 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 112/23. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO       For further information: Stig Frederiksen, Head

#teamZalaris finishes Zalaris Norseman Xtreme Triathlon – known as the toughest triathlon in the world

For the fourth year in a row, Zalaris proudly sponsors the Zalaris Norseman Xtreme Triathlon. This unique event aims to ‘inspire and demonstrate the robustness of what ordinary people can achieve’.#teamZalaris for Norseman 2023 comprises of Torsten Neufeld, Anders Spilling, Sophie Buer, Stanisław Kłęk, Simone Kragh Jacobsen, Ross Creber and Andreas Martinussen. The team has raised over 550,000 NOK benefitting  AKTIV Against Cancer , The 5k Your Way  Initiative, provided by MOVE Charity , Hopp Children's Cancer

There are no items matching the current filter
There are no more items matching the current filter
Back to top